MEGIN announces New Distributor Partnership with Aerobe in India
by MEGIN | March 13, 2026 | MEGIN news
HELSINKI, FINLAND. March 13, 2025 – MEGIN, a global leader in functional neuroimaging and magnetoencephalography (MEG) solutions, is pleased to announce a new distributor partnership with Aerobe, strengthening MEGIN’s presence and service capabilities across the Indian market.
Following a rigorous selection process, MEGIN has appointed Aerobe as its distributor in India based on the company’s deep neuroscience expertise, strong clinical focus, and proven track record in representing advanced medical technologies. The partnership is established to support the rapidly growing interest in the country from hospitals and research facilities wanting to bring this important modality to their neuroimaging programs, in addition to supporting MEGIN’s existing customer base in India. Aerobe will provide localized sales, application support, and service following comprehensive training by MEGIN.
Aerobe operates across three core verticals: Neurosciences, Physiotherapy, and Aesthetics, and represents more than 40 carefully selected manufacturers, chosen for their scientific credibility, clinical value, and innovation potential. Each vertical is supported by dedicated teams with deep technical and scientific expertise. From neuromodulation and brain mapping to advanced rehabilitation platforms and non-invasive aesthetics, Aerobe delivers technologies that enable healthcare professionals to provide more personalized, effective, and efficient care.“At Aerobe, we empower researchers and clinicians with advanced technologies and insight—driving discovery and delivering better care.”
Founded in 1996, Aerobe was established to bring advanced medical solutions to the forefront of patient care. What began with a single employee and a strong belief in the power of technology has grown into a high-performance organization of over 60 professionals. Today, Aerobe is a trusted partner in the distribution of high-impact medical technologies across India.
Through this partnership, Aerobe will represent MEGIN’s market-leading TRIUX™ neo system. TRIUX™ neo delivers a non-invasive, real-time view of patient-specific neural activity with millimeter accuracy and millisecond resolution, providing the most precise information currently available on the market.
Approved in clinical use and research to record brain activity, the system sets a new benchmark in functional brain mapping, to support confident, data-driven decision-making in neurosurgical planning.
With the unique combination of spatial and temporal resolution unmatched by other neuroimaging technologies, MEGIN’s TRIUX™ neo is widely regarded as the gold standard in MEG technology — striving to advance neuroscience research and transform patient care worldwide.
Commenting on the new partnership, Gordon Baltzer, President of MEGIN, said:
“India is a strategically important and rapidly advancing market for neuroscience research and clinical innovation. Aerobe’s depth of neuro expertise, commitment to scientific excellence, and strong service-oriented approach make them an ideal partner for MEGIN. Together, we look forward to supporting clinicians and researchers across India with best-in-class MEG technology and local expertise.”
About MEGIN
MEGIN is a global neuroscience technology company focused on developing innovative solutions for functional brain mapping for presurgical evaluation. For over 30 years, MEGIN has been the global leader in magnetoencephalography (MEG) technology. The TRIUX™ neo provides a non-invasive, real-time view of patient-specific neural activity with millimeter accuracy and millisecond resolution, providing the most precise information currently available on the market.
Copyright 2026 © MEGIN – TRIUX™ neo is available for sale in the European Union, UK, Japan, Canada, the United States, as well as certain other countries. In other geographical areas, contact your local MEGIN representative. TRIUX™ neo is intended for use as a magnetoencephalographic (MEG) device that non-invasively detects and displays biomagnetic signals produced by electrically active nerve tissue in the brain. When interpreted by a trained clinician, the data enhances the diagnostic capability by providing useful information about the location relative to the brain anatomy of active nerve tissue responsible for critical brain functions.
Website
www.megin.com
Sales & Media Contact
info@megin.com
Aerobe website:
Aerobe sales contact: